Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stomach Neoplasms | 16 | 2024 | 1457 | 1.650 |
Why?
|
Pancreatic Neoplasms | 8 | 2022 | 5366 | 1.440 |
Why?
|
Pancreatectomy | 5 | 2022 | 811 | 1.300 |
Why?
|
Adenocarcinoma | 15 | 2024 | 6341 | 1.190 |
Why?
|
Veterans Health | 3 | 2022 | 215 | 1.030 |
Why?
|
Carcinoid Tumor | 3 | 2012 | 225 | 1.030 |
Why?
|
Pancreaticoduodenectomy | 5 | 2020 | 509 | 0.960 |
Why?
|
Gastrointestinal Stromal Tumors | 5 | 2009 | 617 | 0.800 |
Why?
|
Biliary Tract | 1 | 2019 | 135 | 0.600 |
Why?
|
Bile | 1 | 2019 | 297 | 0.590 |
Why?
|
Nomograms | 2 | 2009 | 230 | 0.540 |
Why?
|
Appendicitis | 1 | 2023 | 676 | 0.530 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2015 | 152 | 0.470 |
Why?
|
Hepatectomy | 3 | 2019 | 557 | 0.470 |
Why?
|
Neoplasm Staging | 10 | 2016 | 11119 | 0.470 |
Why?
|
Colonic Neoplasms | 3 | 2014 | 2527 | 0.470 |
Why?
|
Chemokine CCL20 | 1 | 2014 | 64 | 0.460 |
Why?
|
Piperazines | 4 | 2009 | 2522 | 0.450 |
Why?
|
Receptors, CCR6 | 1 | 2014 | 74 | 0.450 |
Why?
|
Genes, APC | 1 | 2014 | 145 | 0.440 |
Why?
|
Interleukin-17 | 2 | 2015 | 913 | 0.410 |
Why?
|
Esophageal Neoplasms | 5 | 2024 | 1658 | 0.410 |
Why?
|
Pyrimidines | 4 | 2009 | 3027 | 0.400 |
Why?
|
Lymphatic Metastasis | 8 | 2018 | 2913 | 0.400 |
Why?
|
Healthcare Disparities | 3 | 2022 | 3354 | 0.390 |
Why?
|
Esophagogastric Junction | 5 | 2024 | 347 | 0.390 |
Why?
|
Colectomy | 2 | 2020 | 686 | 0.390 |
Why?
|
Colorectal Neoplasms | 7 | 2021 | 6919 | 0.390 |
Why?
|
Pancreas | 4 | 2022 | 1684 | 0.380 |
Why?
|
Intestinal Neoplasms | 1 | 2014 | 315 | 0.380 |
Why?
|
Survival Rate | 11 | 2021 | 12728 | 0.380 |
Why?
|
Lymph Node Excision | 4 | 2016 | 1270 | 0.380 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2015 | 592 | 0.370 |
Why?
|
Lymph Nodes | 3 | 2011 | 3461 | 0.370 |
Why?
|
Early Diagnosis | 1 | 2016 | 1186 | 0.370 |
Why?
|
Postoperative Complications | 8 | 2020 | 15637 | 0.360 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2006 | 955 | 0.350 |
Why?
|
Vaccines, DNA | 4 | 2006 | 280 | 0.340 |
Why?
|
Health Status Disparities | 1 | 2021 | 1847 | 0.340 |
Why?
|
Patient Discharge | 5 | 2020 | 3441 | 0.330 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1726 | 0.310 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2016 | 876 | 0.300 |
Why?
|
Veterans | 1 | 2022 | 2656 | 0.300 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2820 | 0.300 |
Why?
|
Antineoplastic Agents | 7 | 2015 | 13632 | 0.290 |
Why?
|
Incidental Findings | 1 | 2012 | 698 | 0.280 |
Why?
|
Duodenal Neoplasms | 1 | 2007 | 114 | 0.280 |
Why?
|
Bile Ducts | 2 | 2019 | 284 | 0.280 |
Why?
|
Socioeconomic Factors | 4 | 2022 | 7804 | 0.270 |
Why?
|
Melanoma | 7 | 2023 | 5694 | 0.270 |
Why?
|
Prognosis | 16 | 2024 | 29688 | 0.260 |
Why?
|
Antigens, Heterophile | 2 | 2003 | 70 | 0.260 |
Why?
|
Gastrectomy | 6 | 2018 | 672 | 0.260 |
Why?
|
Mediastinal Diseases | 1 | 2006 | 91 | 0.250 |
Why?
|
Digestive System Surgical Procedures | 2 | 2016 | 571 | 0.250 |
Why?
|
Sternum | 1 | 2006 | 175 | 0.250 |
Why?
|
Cholestasis | 2 | 2019 | 378 | 0.240 |
Why?
|
Skilled Nursing Facilities | 2 | 2019 | 400 | 0.240 |
Why?
|
Streptococcus bovis | 1 | 2004 | 4 | 0.240 |
Why?
|
Hyperparathyroidism | 1 | 2006 | 337 | 0.240 |
Why?
|
SEER Program | 3 | 2015 | 1453 | 0.220 |
Why?
|
Insurance, Health | 1 | 2016 | 2493 | 0.220 |
Why?
|
Aged | 37 | 2024 | 169292 | 0.220 |
Why?
|
Protein Kinase Inhibitors | 3 | 2009 | 5665 | 0.210 |
Why?
|
Middle Aged | 40 | 2024 | 220858 | 0.210 |
Why?
|
Humans | 67 | 2024 | 761222 | 0.210 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2007 | 732 | 0.200 |
Why?
|
Melanoma, Experimental | 2 | 2003 | 561 | 0.200 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2018 | 736 | 0.200 |
Why?
|
Cardia | 2 | 2020 | 60 | 0.200 |
Why?
|
Patient Transfer | 2 | 2019 | 794 | 0.190 |
Why?
|
Benzamides | 4 | 2009 | 1371 | 0.190 |
Why?
|
Aged, 80 and over | 20 | 2024 | 58952 | 0.190 |
Why?
|
Skin Neoplasms | 4 | 2023 | 5809 | 0.180 |
Why?
|
Neoadjuvant Therapy | 4 | 2019 | 2827 | 0.180 |
Why?
|
Male | 44 | 2024 | 360703 | 0.180 |
Why?
|
Fibroma | 1 | 2002 | 190 | 0.180 |
Why?
|
Female | 44 | 2024 | 392552 | 0.170 |
Why?
|
Streptococcal Infections | 1 | 2004 | 617 | 0.170 |
Why?
|
Appendectomy | 1 | 2023 | 434 | 0.170 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2003 | 822 | 0.160 |
Why?
|
Cell Proliferation | 5 | 2018 | 10423 | 0.160 |
Why?
|
Neoplasm Invasiveness | 6 | 2018 | 3590 | 0.160 |
Why?
|
Cancer Vaccines | 3 | 2003 | 1038 | 0.160 |
Why?
|
Reoperation | 3 | 2019 | 4303 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 6 | 2024 | 6486 | 0.150 |
Why?
|
Retrospective Studies | 17 | 2021 | 80675 | 0.150 |
Why?
|
Neoplasm Proteins | 3 | 2011 | 3594 | 0.150 |
Why?
|
Thymosin | 1 | 1997 | 47 | 0.150 |
Why?
|
Oncolytic Virotherapy | 1 | 2023 | 515 | 0.150 |
Why?
|
Rehabilitation Centers | 1 | 2019 | 246 | 0.140 |
Why?
|
Patient Selection | 1 | 2009 | 4246 | 0.140 |
Why?
|
Bacteremia | 1 | 2004 | 978 | 0.140 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6125 | 0.140 |
Why?
|
Heart Neoplasms | 1 | 2020 | 364 | 0.140 |
Why?
|
Hospices | 1 | 2019 | 245 | 0.140 |
Why?
|
Length of Stay | 5 | 2020 | 6417 | 0.130 |
Why?
|
Transcription Factors | 1 | 2015 | 12101 | 0.130 |
Why?
|
Proportional Hazards Models | 7 | 2015 | 12474 | 0.130 |
Why?
|
Membrane Glycoproteins | 3 | 2003 | 3696 | 0.130 |
Why?
|
Cell Movement | 2 | 2018 | 5195 | 0.120 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1097 | 0.120 |
Why?
|
Immunoenzyme Techniques | 2 | 2014 | 1703 | 0.120 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39127 | 0.120 |
Why?
|
Morbidity | 1 | 2020 | 1751 | 0.120 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 353 | 0.120 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2019 | 3512 | 0.120 |
Why?
|
Digestive System Diseases | 1 | 2016 | 151 | 0.120 |
Why?
|
Choristoma | 1 | 2016 | 205 | 0.120 |
Why?
|
Risk Factors | 14 | 2024 | 74241 | 0.110 |
Why?
|
Carcinoma | 2 | 2015 | 2330 | 0.110 |
Why?
|
Sex Factors | 4 | 2021 | 10553 | 0.110 |
Why?
|
Carcinoma, Lobular | 1 | 1997 | 480 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2002 | 1158 | 0.110 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1348 | 0.100 |
Why?
|
Adult | 22 | 2018 | 221120 | 0.100 |
Why?
|
Specialties, Surgical | 1 | 2017 | 389 | 0.100 |
Why?
|
Acute Disease | 1 | 2023 | 7226 | 0.100 |
Why?
|
Cell Adhesion Molecules | 1 | 1998 | 1603 | 0.100 |
Why?
|
Liver Neoplasms | 1 | 2008 | 4310 | 0.100 |
Why?
|
Carcinoma in Situ | 1 | 1997 | 791 | 0.100 |
Why?
|
Treatment Outcome | 9 | 2023 | 64681 | 0.100 |
Why?
|
China | 5 | 2016 | 2374 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2008 | 9278 | 0.100 |
Why?
|
Microscopy, Confocal | 1 | 2017 | 1967 | 0.090 |
Why?
|
Respiratory Tract Diseases | 1 | 2017 | 748 | 0.090 |
Why?
|
Time Factors | 8 | 2020 | 39957 | 0.090 |
Why?
|
Stomach | 1 | 2015 | 697 | 0.090 |
Why?
|
Peritoneum | 1 | 2012 | 225 | 0.090 |
Why?
|
Stromal Cells | 1 | 2016 | 1329 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 1997 | 1084 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2016 | 15308 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 1 | 2014 | 2468 | 0.080 |
Why?
|
Survival Analysis | 6 | 2008 | 10088 | 0.080 |
Why?
|
Phosphoproteins | 1 | 1998 | 2444 | 0.080 |
Why?
|
Perioperative Care | 1 | 2017 | 1037 | 0.080 |
Why?
|
Mitotic Index | 1 | 2009 | 162 | 0.080 |
Why?
|
Risk Assessment | 7 | 2019 | 24022 | 0.080 |
Why?
|
Stents | 2 | 2020 | 3177 | 0.080 |
Why?
|
Neoplasm Metastasis | 4 | 2007 | 4909 | 0.080 |
Why?
|
World Health Organization | 1 | 2015 | 1321 | 0.080 |
Why?
|
Computational Biology | 1 | 2021 | 3499 | 0.080 |
Why?
|
Spain | 1 | 2009 | 489 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2021 | 5301 | 0.070 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2011 | 646 | 0.070 |
Why?
|
Telomere | 1 | 2013 | 939 | 0.070 |
Why?
|
Mice | 11 | 2018 | 81330 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4567 | 0.070 |
Why?
|
Dacarbazine | 1 | 2010 | 559 | 0.070 |
Why?
|
Tumor Burden | 1 | 2013 | 1892 | 0.070 |
Why?
|
Adolescent | 9 | 2016 | 88300 | 0.070 |
Why?
|
Blotting, Western | 1 | 2014 | 5032 | 0.070 |
Why?
|
Immunotherapy, Active | 1 | 2006 | 58 | 0.070 |
Why?
|
gp100 Melanoma Antigen | 2 | 2003 | 38 | 0.070 |
Why?
|
Mice, Inbred C57BL | 7 | 2014 | 22128 | 0.070 |
Why?
|
Fluorouracil | 1 | 2011 | 1642 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2008 | 726 | 0.060 |
Why?
|
Disease-Free Survival | 3 | 2009 | 6819 | 0.060 |
Why?
|
Metaplasia | 2 | 2020 | 324 | 0.060 |
Why?
|
Young Adult | 5 | 2016 | 59222 | 0.060 |
Why?
|
Esophagus | 1 | 2011 | 1036 | 0.060 |
Why?
|
Endoscopy | 2 | 2015 | 1852 | 0.060 |
Why?
|
Databases as Topic | 1 | 2007 | 473 | 0.060 |
Why?
|
Combined Modality Therapy | 3 | 2013 | 8519 | 0.060 |
Why?
|
Autoantigens | 2 | 2006 | 888 | 0.060 |
Why?
|
United States | 6 | 2019 | 72341 | 0.060 |
Why?
|
Age Factors | 3 | 2020 | 18384 | 0.060 |
Why?
|
Incidence | 3 | 2018 | 21366 | 0.060 |
Why?
|
Animals | 13 | 2021 | 168089 | 0.060 |
Why?
|
Asparagine | 1 | 2003 | 120 | 0.050 |
Why?
|
Massachusetts | 1 | 2016 | 8837 | 0.050 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2003 | 359 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2006 | 4373 | 0.050 |
Why?
|
Databases, Factual | 4 | 2020 | 7965 | 0.050 |
Why?
|
H-2 Antigens | 1 | 2003 | 358 | 0.050 |
Why?
|
Injections, Intraperitoneal | 1 | 2003 | 413 | 0.050 |
Why?
|
Apoptosis | 2 | 2018 | 9478 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8531 | 0.050 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2003 | 1351 | 0.050 |
Why?
|
Tibial Nerve | 1 | 2002 | 50 | 0.050 |
Why?
|
Comorbidity | 3 | 2020 | 10516 | 0.050 |
Why?
|
Prospective Studies | 5 | 2018 | 54437 | 0.050 |
Why?
|
Peroneal Nerve | 1 | 2002 | 76 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3418 | 0.050 |
Why?
|
Genes, Neoplasm | 1 | 2003 | 370 | 0.050 |
Why?
|
Adjuvants, Immunologic | 1 | 2006 | 988 | 0.050 |
Why?
|
Neoplasms | 3 | 2006 | 22142 | 0.050 |
Why?
|
Tryptophan | 1 | 2003 | 480 | 0.050 |
Why?
|
Denervation | 1 | 2002 | 265 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2018 | 1822 | 0.040 |
Why?
|
Patient Readmission | 3 | 2020 | 3265 | 0.040 |
Why?
|
Neoplasms, Experimental | 1 | 2006 | 1225 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2018 | 3593 | 0.040 |
Why?
|
Ostomy | 1 | 2020 | 33 | 0.040 |
Why?
|
Barrett Esophagus | 1 | 2024 | 492 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20588 | 0.040 |
Why?
|
Age Distribution | 2 | 2016 | 2871 | 0.040 |
Why?
|
Quality Improvement | 3 | 2020 | 3808 | 0.040 |
Why?
|
Child | 4 | 2011 | 80154 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2014 | 12747 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16954 | 0.040 |
Why?
|
Catenins | 1 | 1998 | 44 | 0.040 |
Why?
|
Limb Salvage | 1 | 2002 | 480 | 0.040 |
Why?
|
Mice, Knockout | 1 | 2014 | 14392 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2003 | 1737 | 0.040 |
Why?
|
Oximes | 1 | 2020 | 303 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9187 | 0.040 |
Why?
|
Sciatic Nerve | 1 | 2002 | 618 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2015 | 11512 | 0.040 |
Why?
|
Rhabdomyosarcoma | 1 | 2001 | 358 | 0.040 |
Why?
|
Autoimmunity | 1 | 2006 | 1356 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2015 | 11067 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14610 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2015 | 5145 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2020 | 385 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2006 | 13402 | 0.040 |
Why?
|
Ureter | 1 | 2020 | 368 | 0.040 |
Why?
|
Helicobacter pylori | 1 | 2020 | 382 | 0.040 |
Why?
|
Fluorescein | 1 | 2017 | 175 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2006 | 2426 | 0.030 |
Why?
|
Helicobacter Infections | 1 | 2020 | 392 | 0.030 |
Why?
|
Uveal Neoplasms | 1 | 2020 | 341 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2002 | 1008 | 0.030 |
Why?
|
Colonoscopy | 1 | 2004 | 1395 | 0.030 |
Why?
|
Radiography | 1 | 2007 | 6974 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2006 | 4574 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2003 | 2199 | 0.030 |
Why?
|
Health Status | 2 | 2019 | 4077 | 0.030 |
Why?
|
Bilirubin | 1 | 2017 | 436 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 522 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2020 | 1381 | 0.030 |
Why?
|
Gastroscopy | 1 | 2016 | 211 | 0.030 |
Why?
|
Antigens, Neoplasm | 4 | 2006 | 1985 | 0.030 |
Why?
|
Syndecan-1 | 1 | 2015 | 163 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12052 | 0.030 |
Why?
|
Pyridones | 1 | 2020 | 809 | 0.030 |
Why?
|
Breast Diseases | 1 | 1997 | 443 | 0.030 |
Why?
|
Biopsy | 2 | 2016 | 6781 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2006 | 17598 | 0.030 |
Why?
|
North America | 1 | 2018 | 1284 | 0.030 |
Why?
|
Imidazoles | 1 | 2020 | 1172 | 0.030 |
Why?
|
Intramolecular Oxidoreductases | 2 | 2006 | 105 | 0.030 |
Why?
|
Serum Albumin | 1 | 2017 | 674 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2054 | 0.030 |
Why?
|
Registries | 1 | 2009 | 8246 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2000 | 1783 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2002 | 2307 | 0.030 |
Why?
|
Models, Statistical | 1 | 2007 | 5081 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2016 | 1334 | 0.030 |
Why?
|
Logistic Models | 2 | 2019 | 13249 | 0.030 |
Why?
|
Osteoclasts | 1 | 2015 | 711 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1436 | 0.020 |
Why?
|
Cytokines | 1 | 2006 | 7386 | 0.020 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2011 | 87 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2009 | 20118 | 0.020 |
Why?
|
Recovery of Function | 2 | 2017 | 2981 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2277 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11733 | 0.020 |
Why?
|
Protein Binding | 1 | 2003 | 9297 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1641 | 0.020 |
Why?
|
Sarcoma | 1 | 2002 | 1800 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2003 | 5103 | 0.020 |
Why?
|
Thromboembolism | 1 | 2017 | 992 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2017 | 1303 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 1997 | 20982 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2452 | 0.020 |
Why?
|
Forecasting | 1 | 2018 | 2928 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2017 | 1901 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2813 | 0.020 |
Why?
|
Genomic Instability | 1 | 2013 | 709 | 0.020 |
Why?
|
DNA Modification Methylases | 1 | 2010 | 210 | 0.020 |
Why?
|
Postoperative Care | 1 | 2015 | 1468 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1265 | 0.020 |
Why?
|
Breast | 1 | 1997 | 1964 | 0.020 |
Why?
|
Up-Regulation | 1 | 1997 | 4111 | 0.020 |
Why?
|
Telomerase | 1 | 2013 | 741 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2010 | 346 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1789 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2002 | 890 | 0.020 |
Why?
|
Acute-Phase Reaction | 1 | 2006 | 91 | 0.020 |
Why?
|
Hypopigmentation | 1 | 2006 | 43 | 0.020 |
Why?
|
Mice, SCID | 1 | 2011 | 2621 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2008 | 368 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2015 | 3210 | 0.020 |
Why?
|
Self Tolerance | 1 | 2006 | 123 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4642 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5829 | 0.020 |
Why?
|
Mutation | 2 | 2008 | 30004 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2006 | 282 | 0.010 |
Why?
|
Disease Models, Animal | 3 | 2015 | 18222 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2004 | 26200 | 0.010 |
Why?
|
COS Cells | 1 | 2006 | 1129 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2006 | 578 | 0.010 |
Why?
|
Cross Reactions | 1 | 2006 | 819 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2006 | 6504 | 0.010 |
Why?
|
Gene Library | 1 | 2006 | 1054 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10218 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2006 | 1989 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14675 | 0.010 |
Why?
|
Infant | 1 | 2004 | 36170 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3412 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3198 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2003 | 914 | 0.010 |
Why?
|
Child, Preschool | 1 | 2004 | 42225 | 0.010 |
Why?
|
Plasmids | 1 | 2006 | 2261 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12976 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22174 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2015 | 4479 | 0.010 |
Why?
|
Vaccination | 2 | 2003 | 3369 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2803 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2003 | 575 | 0.010 |
Why?
|
Self-Assessment | 1 | 2002 | 399 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2003 | 577 | 0.010 |
Why?
|
Lung Neoplasms | 2 | 2002 | 13386 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5773 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2001 | 918 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2002 | 2010 | 0.010 |
Why?
|
Transfection | 1 | 2006 | 5748 | 0.010 |
Why?
|
Major Histocompatibility Complex | 1 | 2000 | 872 | 0.010 |
Why?
|
Immunization | 1 | 2002 | 1218 | 0.010 |
Why?
|
Diet | 1 | 2015 | 8048 | 0.010 |
Why?
|
Leg | 1 | 2002 | 1087 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2002 | 1743 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2000 | 2175 | 0.010 |
Why?
|
Antibody Formation | 1 | 2000 | 1391 | 0.010 |
Why?
|
DNA Methylation | 1 | 2010 | 4384 | 0.010 |
Why?
|
Base Sequence | 1 | 2006 | 12404 | 0.010 |
Why?
|
Testicular Neoplasms | 1 | 2001 | 801 | 0.010 |
Why?
|
Spleen | 1 | 2000 | 2290 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2003 | 6200 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2003 | 2802 | 0.010 |
Why?
|
Graft Rejection | 1 | 2006 | 4481 | 0.010 |
Why?
|
Cell Division | 1 | 2000 | 4451 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2003 | 2726 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2000 | 3388 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2006 | 10203 | 0.000 |
Why?
|
Quality of Life | 1 | 2002 | 13367 | 0.000 |
Why?
|